Sanara MedTech Inc. reported fourth quarter 2025 net revenue of $27.5 million, up 5% from $26.3 million in Q4 2024, and full year 2025 net revenue of $103.1 million, up 19% from $86.7 million in 2024, with Adjusted EBITDA of $17.0 million. The company reaffirmed full year 2026 net revenue guidance of $116 million to $121 million.
Key takeaways
Net revenue Q4 2025 $27.5 million vs $26.3 million Q4 2024
Net revenue FY 2025 $103.1 million vs $86.7 million FY 2024
Adjusted EBITDA Q4 2025 $4.7 million vs $4.1 million Q4 2024
Adjusted EBITDA FY 2025 $17.0 million vs $9.1 million FY 2024
FY 2026 net revenue guidance $116 million to $121 million
Cash $16.6 million and long-term debt $46.0 million as of December 31, 2025
BIASURGE received Innovative Technology contract from Vizient effective January 1, 2026